Tag: lenders

Co-Founder and Chief Executive Officer Elias Sabo to Retire at Year End

This new capital will accelerate the deployment of Nesto Cloud’s AI-powered lending platform across the mortgage financing and financial services sectors.

SOUTH PASADENA, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- San Gabriel Valley Real Estate Broker Dave Knight, of the Dave Knight Real Estate Team of Keller Williams (DKRE), announced they are exclusively listing eight former Caltrans properties on behalf of the City of South Pasadena. These residential properties, including the historic Columbia House, were acquired by Caltrans through eminent domain to build the now-defunct 710 Freeway extension through the city. Now, these homes will be returned to the residential real estate market for new owners to enjoy. 

NEW YORK, June 07, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

Initiates voluntary prepackaged Chapter 11 process to implement Restructuring Transactions that have the support of 100% of its lenders, over 60% of the holders of GoHealth, Inc. Class A Common Stock, and over 99% of the holders of GoHealth Holdings, LLC interests.

National IOS leader secures loan from Blackstone Real Estate Debt Strategies to support rapidly growing industrial outdoor storage platform

RALEIGH, N.C., June 04, 2026 (GLOBE NEWSWIRE) -- Highwoods Properties, Inc. (NYSE:HIW) has executed a recast of a $150 million unsecured bank term loan by extending the maturity date from May 2027 to June 2031, inclusive of two one-year extension options that are exercisable at the Company’s option assuming no defaults have occurred.

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Barclays PLC (NYSE: BCS) resulting from allegations that Barclays may have issued materially misleading business information to the investing public.

MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (“Celcuity” or the “Company”), a clinical-stage biotechnology company focused on the development of targeted therapies for the treatment of multiple solid tumor indications, today announced the pricing of its upsized underwritten public offering of $500,000,000 aggregate principal amount of its 0.250% convertible senior notes due 2032 (the “Convertible Notes”). The aggregate principal amount of the offering was increased from the previously announced offering size of $400,000,000.